57
Views
17
CrossRef citations to date
0
Altmetric
Original

Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder

, , , , , , & show all
Pages 602-612 | Received 29 Aug 2003, Accepted 21 Apr 2004, Published online: 07 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (17)

Samantha Galea, Catherine Wade, Chloe A. Salvaris, Marie B. H. Yap & Katherine A. Lawrence. (2022) Acceptability of an enhanced transdiagnostic CBT intervention for adults with anxiety disorders who are parenting an anxious child. Clinical Psychologist 26:2, pages 141-155.
Read now
D. Scott Sibley, Alexandra E. Schmidt & Jonathan G. Kimmes. (2015) Applying a Contextual Therapy Framework to Treat Panic Disorder: A Case Study. Journal of Family Psychotherapy 26:4, pages 299-317.
Read now
Marina De Salas-Cansado, José M Olivares, Enrique Álvarez, Jose L Carrasco, Andoni Barrueta & Javier Rejas. (2012) Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain. ClinicoEconomics and Outcomes Research 4, pages 157-168.
Read now
Anthony F. Jorm. (2011) Australia's Better Access initiative: do the evaluation data support the critics?. Australian and New Zealand Journal of Psychiatry 45:9, pages 700-704.
Read now
Daniela Solomon, Emily Ford, Jon Adams & Nicholas Graves. (2011) Potential of St John's Wort for the treatment of depression: the economic perspective. Australian and New Zealand Journal of Psychiatry 45:2, pages 123-130.
Read now
Erik Hedman, Brjánn Ljótsson, Erik Andersson, Christian Rück, Gerhard Andersson & Nils Lindefors. (2010) Effectiveness and Cost Offset Analysis of Group CBT for Hypochondriasis Delivered in a Psychiatric Setting: An Open Trial. Cognitive Behaviour Therapy 39:4, pages 239-250.
Read now
Paul McCrone, IsaacM. Marks, David Mataix‐Cols, Mark Kenwright & Michael McDonough. (2009) Computer‐Aided Self‐Exposure Therapy for Phobia/Panic Disorder: A Pilot Economic Evaluation. Cognitive Behaviour Therapy 38:2, pages 91-99.
Read now
Michael Iskedjian, John H. Walker, Basil G. Bereza, Jean‑Michel Le Melledo & Thomas R. Einarson. (2008) Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada. Current Medical Research and Opinion 24:5, pages 1539-1548.
Read now
C. Allgulander, T. Jørgensen, A. Wade, C. François, N. Despiegel, P. Auquier & M. Toumi. (2007) Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial. Current Medical Research and Opinion 23:10, pages 2543-2549.
Read now
Michael E Thase. (2006) Treatment of anxiety disorders with venlafaxine XR. Expert Review of Neurotherapeutics 6:3, pages 269-282.
Read now
Ruth Williams & Darrel Doessel. (2006) A report on economic studies of Australian mental health issues. Australasian Psychiatry 14:2, pages 141-145.
Read now
Ian Hickie, Tracey Davenport, Georgina Luscombe, Elizabeth Scott, Elizabeth Mackenzie, Hugh Morgan, Andrew Wilson, David Barton & Elaine Barrett. (2006) Is real reform of the Medicare Benefits Schedule for psychiatrists in Australia economically, socially or professionally desirable?. Australasian Psychiatry 14:1, pages 8-14.
Read now
Michelle M. Haby, Marie Donnelly, Justine Corry & Theo Vos. (2006) Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Australian and New Zealand Journal of Psychiatry 40:1, pages 9-19.
Read now
Malcolm Lader. (2005) Management of panic disorder. Expert Review of Neurotherapeutics 5:2, pages 259-266.
Read now
Dan Chisholm. (2005) Keeping pace with Assessing Cost-effectiveness: economic efficiency and priority-setting in mental health. Australian and New Zealand Journal of Psychiatry 39:8, pages 645-647.
Read now
Theo Vos, Michelle M. Haby, Anne Magnus, Cathrine Mihalopoulos, Gavin Andrews & Rob Carter. (2005) Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services. Australian and New Zealand Journal of Psychiatry 39:8, pages 701-712.
Read now
Theo Vos, Justine Corry, Michelle M. Haby, Rob Carter & Gavin Andrews. (2005) Cost-effectiveness of cognitive–behavioural therapy and drug interventions for major depression. Australian and New Zealand Journal of Psychiatry 39:8, pages 683-692.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.